---
title: "Clinigen Pharma Limited — Ownership Dossier"
canonical: https://whiteintel.dev/entity/2eea595e-4911-5cf6-b68f-614844600cd6
json: https://whiteintel.dev/api/public/dossier/2eea595e-4911-5cf6-b68f-614844600cd6
identifier: oo:GB-COH-04813750
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Clinigen Pharma Limited

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-04813750`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/2eea595e-4911-5cf6-b68f-614844600cd6  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/2eea595e-4911-5cf6-b68f-614844600cd6  

## Cross-source identity

The same real-world entity, resolved across sources:

- **CLINIGEN PHARMA LIMITED** — OpenOwnership · `oo:GB-COH-07248508` — https://whiteintel.dev/entity/c73b61a9-95e6-57e2-b6e3-10586e881102
- **Clinigen Pharma Limited** — source · `psc:wEB73yKXJHlGfsti62mfdqjZrcU` — https://whiteintel.dev/entity/903864f0-a67d-4cba-908b-24054495f31e
- **Clinigen Pharma Limited** — source · `psc:UWxIim2ZuGJdAv-QPs0sHGtzZrc` — https://whiteintel.dev/entity/0f3276a1-9a76-4510-a79c-02248aafff70
- **Clinigen Pharma Limited** — source · `psc:XYCDYxLSXdAVPZXry42VRGINVFk` — https://whiteintel.dev/entity/2505da54-2352-46bf-930c-045990188d75
- **Clinigen Pharma Limited** — OpenOwnership · `oo:GB-COH-07869194` — https://whiteintel.dev/entity/8bb575fc-a5ec-552e-b42d-dcd28c5b25af

## Ownership & control

### Owners / controllers

- **Clinigen Pharma Limited** (beneficial owner) — 100% — https://whiteintel.dev/entity/2eea595e-4911-5cf6-b68f-614844600cd6
- **Clinigen Pharma Limited** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/0f3276a1-9a76-4510-a79c-02248aafff70

### Holdings / subsidiaries

- **CLINIGEN CTS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/c85e0ee5-d306-5330-8fa4-962d75228258

### UBO chain (walk to the ultimate owner)

A **17-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `04813750`
- **Status:** dissolved
- **Type:** ltd
- **Incorporated:** 2003-06-27
- **Registered office:** Pitcairn House Crown Square, Centrum 100, Burton On Trent, Staffordshire, DE14 2WW
- **SIC:** 99999

### Officers

- PALING, Richard John — director · British · appointed 2021-08-24
- ABELL, Martin James — secretary · appointed 2017-03-02 · resigned 2017-07-13
- HADDLETON, James Sidney — secretary · appointed 2015-11-02 · resigned 2017-03-02
- LEAVER, Linda — secretary · English · appointed 2003-07-01 · resigned 2010-06-18
- MILLER, Amanda — secretary · appointed 2017-07-13 · resigned 2023-01-16
- SIBSON, Robin Andrew John — secretary · British · appointed 2011-07-31 · resigned 2015-11-02
- WOOD, Robert Macgregor Warburton — secretary · British · appointed 2010-06-18 · resigned 2011-07-31
- ARGUS NOMINEE SECRETARIES LIMITED — corporate nominee secretary · appointed 2003-06-27 · resigned 2003-07-01
- ABELL, Martin James — director · British · appointed 2015-12-01 · resigned 2019-03-19
- CHILTON, Shaun Edward — director · British · appointed 2014-04-01 · resigned 2022-10-14
- COTTERILL, Jeremy Paul — director · British · appointed 2007-11-09 · resigned 2010-03-25
- GEORGE, Peter Lutz — director · British · appointed 2010-06-18 · resigned 2016-11-11
- KEHER, Nicholas Patrick — director · British · appointed 2019-03-19 · resigned 2021-08-24
- LEAVER, Andrew Derrick — director · British · appointed 2003-07-01 · resigned 2010-06-18
- LEAVER, Linda — director · English · appointed 2003-07-01 · resigned 2010-06-18
- SIBSON, Robin Andrew John — director · British · appointed 2012-02-14 · resigned 2015-12-01
- WILSON, Christopher — director · British · appointed 2007-11-09 · resigned 2011-06-30
- [ADL HEALTHCARE LIMITED](https://whiteintel.dev/entity/d3f2b5fb-df97-51e5-99d1-5293d55c9e44) — corporate director · appointed 2010-06-18 · resigned 2012-02-14
- ARGUS NOMINEE DIRECTORS LIMITED — corporate nominee director · appointed 2003-06-27 · resigned 2003-07-01

### Beneficial owners (Persons with Significant Control)

- Clinigen Pharma Limited — 75–100% shares · corporate PSC · England — since 2017-06-28

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/04813750

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **Clinigen Pharma Limited** — https://whiteintel.dev/entity/2eea595e-4911-5cf6-b68f-614844600cd6 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Clinigen Pharma Limited**. Human view: https://whiteintel.dev/entity/2eea595e-4911-5cf6-b68f-614844600cd6 · Structured JSON: https://whiteintel.dev/api/public/dossier/2eea595e-4911-5cf6-b68f-614844600cd6._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._